NCT01845337View on ClinicalTrials.gov

Study to Compare Cardiovascular Side Effects of Teysuno Versus Capecitabine

PHASE2CompletedINTERVENTIONAL
Enrollment

59

Participants

Timeline

Start Date

February 5, 2014

Primary Completion Date

March 18, 2020

Study Completion Date

October 8, 2020

Conditions
Gastrointestinal CancerCancer of Unknown Primary SitePancreatic CancerBile Duct Neoplasms
Interventions
DRUG

Teysuno

DRUG

Capecitabine

Trial Locations (1)

EH4 2XU

Edinburgh Cancer Centre, Edinburgh

All Listed Sponsors
collaborator

NHS Lothian

OTHER_GOV

lead

University of Edinburgh

OTHER

NCT01845337 - Study to Compare Cardiovascular Side Effects of Teysuno Versus Capecitabine | Biotech Hunter | Biotech Hunter